Status:
COMPLETED
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Conditions:
Preeclampsia
Eligibility:
FEMALE
18-60 years
Brief Summary
The purpose of this study is to determine whether the Fetal Medicine Foundation algorithm for individual risk calculation for preeclampsia (PE) and pregnancy induced hypertension (PIH) is suitable to ...
Detailed Description
It has been shown that low dose acetylsalicylic acid (ASA) in pregnancy reduces adverse outcome of pregnancy in women that have high risk of developing preeclampsia (PE). It is a challenge for the cli...
Eligibility Criteria
Inclusion
- Pregnant
- Nulliparous
- Para 1+ with previous preeclampsia or gestational hypertension
- last menstrual period (LMP) pregnancy length at inclusion \< 13 weeks
- Residence in Trondheim + 8 surrounding municipalities
Exclusion
- Pregnancy length \> 13+6 weeks (CRL \> 85 mm)
- Twins
- Missed abortion
- Fetal anomaly
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
602 Patients enrolled
Trial Details
Trial ID
NCT01195441
Start Date
September 1 2010
End Date
October 1 2013
Last Update
February 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Center for Fetal Medicine, St Olavs Hospital
Trondheim, Norway, 7006 Trondheim